DLA Piper has played a pivotal role as legal counsel in the recent Hong Kong Stock Exchange (HKEX) Initial Public Offering (IPO) of 160 Health International Limited, which significantly raised around HKD 400 million. This successful listing not only highlights the firm's adeptness in handling complex financial transactions but also underscores the robust fundamentals of 160 Health and the burgeoning digital healthcare market in China.

Shenwan Hongyuan Capital (H.K.) Ltd. and Zero2IPO Capital Ltd. were appointed as the Joint Sponsors for this significant financial maneuver, ensuring a smooth and effective market debut.

The DLA Piper team, led by George Wu, Partner and Co-Head of Equity Capital Markets for EMEA & Asia Pacific, included a formidable lineup of experts such as Senior Associate Jack Li, registered foreign lawyers Jessica Sun and Yu Sun, associate Marcus Ng, legal officer Ivy Chung, and legal assistants Nicholas Chan, Lily Choi, along with trainee solicitor Bernie Wong. Their collective effort was augmented by additional legal insights from Charlotte Wang and Sophia Sun from Shanghai Kaiman Law Firm.

Reflecting on the IPO's success, George Wu remarked, "160 Health’s IPO marks a significant milestone, showcasing the company’s solid market fundamentals and the dynamic growth of China’s digital healthcare sector. We are thrilled to have played a role in this landmark event, reaffirming Hong Kong’s status as a premier global IPO venue."

Earlier in the year, Wu had also spearheaded the firm's advisory role in the HKEX listing of Chifeng Jilong Gold Mining Company, reinforcing DLA Piper’s capability in managing intricate, cross-border IPOs.

160 Health stands out in the healthcare sector by merging pharmaceutical distribution with cutting-edge digital and wellness services. Its platform, Healthcare 160, is recognized as the largest in China’s digital healthcare and wellness arena, connecting a vast network of medical institutions, corporate clients, professionals, individuals, and merchants. This platform is instrumental in digitalizing the healthcare value chain, bringing about transformative changes in the industry.

DLA Piper continues to solidify its reputation as a global law firm with extensive expertise across various sectors. With a presence in over 40 countries, the firm provides comprehensive legal solutions that cater to the needs of multinational corporations, governments, and individuals, delivering strategic and innovative legal services tailored to complex, global challenges.